Is the long‐acting gonadotropin‐releasing hormone agonist long protocol better for patients with endometriosis undergoing IVF?
Authors:
- 5 February 2023
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 162 (1) , 325-332
Abstract
Objective: To investigate the effect of the long‐acting gonadotropin‐releasing hormone agonist (GnRHa) long protocol on in vitro fertilization (IVF) outcomes of patients with endometriosis (EMs).Methods: This retrospective cohort study was carried out from July 1, 2016 to June 30, 2021. In all, 798 patients with EMs who underwent first IVF were enrolled. The patients were classified by the ovarian stimulation protocols. The clinical outcomes of IVF were compared in each group.Results: Those EMs patients who received the long‐acting GnRHa long protocol had significantly higher clinical pregnancy rate (72.00%, 60.70% and 50.90%, respectively; P = 0.047 and 0.010) and implantation rate (51.0%, 44.6%, and 38.7%, respectively; P = 0.006 and P = 0.032), but not statistically different from the short‐acting GnRHa (60.10% vs. 53.80%, P = 0.443). In addition, they also had significantly higher duration of stimulation, total dose of gonadotropin, and number of high‐quality embryos transferred compared with other groups (P < 0.001).Conclusions: The long‐acting GnRHa long protocol could improve IVF outcomes of patients with EMs compared with the short‐acting GnRHa long protocol and the GnRH antagonist protocol.Keywords
Funding Information
- National Natural Science Foundation of China (81601276)
- Natural Science Foundation of Shandong Province (ZR2021MH012)
This publication has 25 references indexed in Scilit:
- Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonistJournal of Gynecology Obstetrics and Human Reproduction, 2017
- KRAS Activation and over-expression of SIRT1/BCL6 Contributes to the Pathogenesis of Endometriosis and Progesterone ResistanceScientific Reports, 2017
- Comparing the long‐acting and short‐acting forms of gonadotropin‐releasing hormone agonists in the long protocol of IVF/ICSI Cycles: A retrospective studyJournal of Obstetrics and Gynaecology Research, 2017
- Does lower dose of long-acting triptorelin maintain pituitary suppression and produce good live birth rate in long down-regulation protocol for in-vitro fertilization?Current Medical Science, 2016
- Experimental research Comparisons of the effects of long-acting and short-acting GnRH agonists on embryo quality, endometrial thickness and pregnancy rate in human in vitro fertilizationArchives of Medical Science, 2014
- Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulationReproductive BioMedicine Online, 2014
- Endometriosis and InfertilityObstetrics and Gynecology Clinics of North America, 2012
- The incidence of aberrant endometrial αvβ3 vitronectin expression in a high risk infertility population: could prolonged GnRH agonist therapy play a role?Journal of Assisted Reproduction and Genetics, 2007
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996Fertility and Sterility, 1997
- High fecundity of amenorrhoeic women in embryo-transfer programmesThe Lancet, 1991